<unk>  is a cell proliferation assay based on the<unk> nhanced proliferation of human breast cancer cells (MCF-7) in the presence of<unk> strogen active substances. The<unk>  test is a tool to<unk> asily and rapidly assess<unk> strogenic activity of suspected xenoestrogens (singly or in combination). This bioassay measures<unk> strogen-induced increase of the number of human breast cancer cell, which is biologically<unk> quivalent to the increase of mitotic activity in tissues of the genital tract. It was originally developed by Soto<unk> t al and was included in the first version of the OECD Conceptual Framework for Testing and Assessment of<unk> ndocrine Disrupters published in 2012. However, due to failed validation, it was not included in the updated version of the framework published in 2018.
E-SCREEN
Cold-fX
WikEM
EMRBots
SWAP-200
FCM 
DCAP-BTLS
RTS,S